Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003768916 | SCV004697395 | likely benign | RPE65-related recessive retinopathy | 2024-02-20 | reviewed by expert panel | curation | NM_000329.3(RPE65):c.1244-5C>T is a non-coding variant in intron 11 near the junction with exon 12. This variant is present in gnomAD v.2.1.1 at a GrpMax allele frequency of 0.002561, with 70 alleles / 24966 total alleles in the African/African-American population, which is higher than the ClinGen LCA / eoRD VCEP BS1 threshold of >0.0008 (BS1). The splicing impact predictor SpliceAI gives scores of 0.26 for acceptor gain and 0.20 for donor gain, which are above the ClinGen LCA / eoRD VCEP recommended threshold of >=0.2 and predict a damaging impact on splicing (PP3). In summary, this variant meets the criteria to be classified as likely benign for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: BS1 and PP3 (VCEP specifications version 1.0.0; date of approval 09/21/2023). |
Labcorp Genetics |
RCV000952401 | SCV001098901 | benign | Leber congenital amaurosis 2; Retinitis pigmentosa 20 | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001273296 | SCV001456170 | uncertain significance | Leber congenital amaurosis | 2020-04-30 | no assertion criteria provided | clinical testing |